Methotrexate Side Effects and Weekly Drug Dose for GPAT

What is it?

Methotrexate is a folate antagonist. It is used for rheumatoid arthritis, psoriasis, and some cancers. Specialists also use it for juvenile idiopathic arthritis, or JIA, in children.

In rheumatoid arthritis, it is a conventional disease-modifying antirheumatic drug, or DMARD. It reduces inflammation and helps prevent joint damage. It is not a quick painkiller. Improvement usually takes several weeks.

Methotrexate side effects are important for GPAT because they connect pharmacology with patient safety. Key risks include mouth ulcers, bone marrow suppression, liver injury, and lung inflammation.

The most important safety rule: low-dose methotrexate for arthritis is taken once weekly, not daily. Taking it daily by mistake can cause fatal poisoning.

This guide covers low-dose treatment for inflammatory disease. Cancer and ectopic pregnancy regimens are different. These notes are for study, not self-treatment.

Dose Chart

The doses below are common starting regimens. A specialist adjusts treatment according to the disease, kidney function, blood tests, and response.

Drug / Form	Adult Dose	Child Dose
Methotrexate, oral tablets	Rheumatoid arthritis: usually 7.5–15 mg once weekly initially. Gradually adjusted; many patients receive 15–25 mg once weekly.	JIA: a common starting dose is 10 mg/m² once weekly, under specialist care.
Methotrexate, subcutaneous injection	Rheumatoid arthritis: usually 7.5–15 mg once weekly initially, with specialist adjustment.	Polyarticular JIA: a common starting dose is 10 mg/m² once weekly. Product instructions and specialist protocols apply.
Folic acid, oral supplement	One common regimen is 5 mg once weekly, on a different day from methotrexate. Other prescribed schedules are also used.	Specialist-prescribed supplementation. The dose and schedule depend on the child's treatment plan.

Dose-chart notes:

• “mg/m²” means milligrams per square metre of body surface area. It does not mean mg/kg.
• Choose a fixed weekly methotrexate day. Check tablet strength carefully.
• Oral and injectable products must not be duplicated accidentally.
• Kidney impairment may require dose reduction or avoidance.
• High-dose cancer treatment needs separate protocols, monitoring, and rescue treatment.

How it Works

Methotrexate interferes with folate-dependent pathways. Folate is needed to make building blocks for DNA.

A classic action is inhibition of dihydrofolate reductase, or DHFR. This reduces the formation of tetrahydrofolate. DNA production falls, especially in rapidly dividing cells. This explains important anticancer effects and several toxic effects.

However, low-dose methotrexate in arthritis works through more than DHFR inhibition. Increased extracellular adenosine is an important part of its anti-inflammatory action. Adenosine reduces inflammatory cell activity.

This distinction is useful in exams: methotrexate is a folate antagonist, but its low-dose anti-inflammatory effect should not be explained only by blocked DNA synthesis.

Folic acid supplementation reduces several treatment-related adverse effects. At prescribed doses, it generally does not meaningfully reduce arthritis control.

Side Effects

Common adverse effects

• Nausea and reduced appetite: These may occur after the weekly dose.
• Mouth ulcers: These can reflect mucosal toxicity. New or severe ulcers need assessment.
• Abdominal discomfort or diarrhoea: Persistent symptoms should be reported.
• Fatigue and mild hair thinning: These may occur during treatment.
• Raised liver enzymes: Blood tests may detect changes before symptoms appear.

Serious adverse effects

Bone marrow suppression: Methotrexate can reduce white blood cells, platelets, and red blood cells. Warning signs include fever, sore throat, unusual bruising, bleeding, or marked weakness.

Liver injury: Long-term treatment can cause serious liver damage. Heavy alcohol use and pre-existing liver disease increase concern.

Methotrexate pneumonitis: This is potentially serious lung inflammation. It can occur even with low-dose treatment. A new dry cough, fever, or breathlessness needs urgent assessment.

Infections: Immune suppression can increase infection risk. Vaccination plans should be reviewed. Live vaccines generally need specialist advice during immunosuppressive treatment.

Embryo-fetal toxicity: Methotrexate can cause fetal harm and pregnancy loss. It is contraindicated in pregnancy for non-cancer conditions. Pregnancy planning and contraception require medical advice.

Interactions and monitoring

Trimethoprim and co-trimoxazole can greatly increase marrow toxicity. They should generally be avoided with methotrexate unless a specialist directs otherwise.

NSAIDs can reduce methotrexate clearance. The risk is greater with high doses or kidney impairment. They are sometimes prescribed with low-dose methotrexate under supervision, but patients should not add them casually.

Monitoring includes a complete blood count, liver function tests, and kidney function tests. These are checked before treatment and regularly afterwards.

Accidental daily dosing needs urgent medical assessment, even without symptoms. Folinic acid, also called leucovorin, is used for rescue in significant toxicity. Ordinary folic acid is not a substitute for emergency treatment.

3 Important Exam Points for GPAT

1. Weekly dosing: Low-dose methotrexate for rheumatoid arthritis and JIA is usually given once weekly. Daily dosing is a dangerous medication error.
2. Characteristic toxicity: Remember bone marrow suppression, hepatotoxicity, mouth ulcers, and pneumonitis. Monitor blood counts, liver function, and kidney function.
3. Rescue drug: Leucovorin is folinic acid. It bypasses DHFR blockade. Routine folic acid supplementation and leucovorin rescue are not interchangeable concepts.

3 MCQs

1. Which schedule is usual for low-dose methotrexate in rheumatoid arthritis?

A. Every four hours
B. Once daily
C. Once weekly
D. Once yearly

Answer: C

2. Which drug is used for rescue from significant methotrexate toxicity?

A. Leucovorin
B. Vitamin K
C. Protamine sulfate
D. Atropine

Answer: A

3. Which antibiotic combination can markedly increase methotrexate-related marrow toxicity?

A. Amoxicillin–clavulanate
B. Trimethoprim–sulfamethoxazole
C. Imipenem–cilastatin
D. Piperacillin–tazobactam

Answer: B

FAQs

Why is folic acid prescribed with methotrexate?

It reduces adverse effects such as mouth ulcers, nausea, and liver enzyme elevations. Follow the prescribed schedule.

Can methotrexate damage the lungs?

Yes. Pneumonitis is uncommon but serious. New breathlessness or a dry cough needs urgent review.

Is methotrexate safe during pregnancy?

It is contraindicated during pregnancy for inflammatory diseases. Anyone planning pregnancy needs specialist advice before treatment changes.

Does everyone develop serious side effects?

No. Many people tolerate monitored treatment well. Correct weekly dosing, interaction checks, and regular blood tests reduce avoidable harm.